LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric CancerZhensong Yang(Qingdao University), Mi Jian(Yuhuangding Hospital)Digestive Diseases and SciencesFebruary 17, 202510.1007/s10620-025-08882-7Cited by 2SaveCiteExport RISWatch citationsRelated PapersPDPN+ cancer-associated fibroblasts correlate with the neoadjuvant immunotherapy response in gastric cancer|APL Bioengineering|2025|1